This discussion will show how USP public standards strengthen quality, streamline development, support regulatory compliance, and overall, increase regulatory predictability for drugs.
Similar Posts
Kilwins Quality Confections, LLC. Issues Allergy Alert on Undeclared Pecans in Mocha Truffles
Kilwins Quality Confections, LLC., of Petoskey, Michigan, is voluntarily recalling Mocha Truffles because they may contain undeclared pecans.Catheter Recall: Medline Industries Removes Reprocessed Electrophysiology and Ultrasound Catheters
Certain reprocessed catheters may contain residual particulates that could cause infection, embolism, or thrombosis.Drug Trials Snapshots: LEROCHOL
Drug Trials Snapshots: LEROCHOLFromi USA Recalls Brie Royal Faucon 1kg Because of Possible Health Risk
FROMI USA of New York, NY is recalling 12 Cases of Brie Royal Faucon 1kg, because they have the potential to be contaminated with Listeria monocytogenesFDA 101: Product Recalls
Recalls are typically voluntary actions taken by a company to remove or correct products on the market that violate U.S. Food and Drug Administration laws and regulations. Recalls may be initiated proactively by a company, at FDA request, or ordered under statutory authority.Tandem Diabetes Care Issues Voluntary Medical Device Correction for Select t:slim X2 Insulin Pumps
SAN DIEGO – August 7, 2025 – Tandem Diabetes Care, Inc. (Nasdaq: TNDM) has announced a voluntary medical device correction for select t:slim X2 insulin pumps to address a potential speaker-related issue that can trigger an error resulting in a discontinuation of insulin delivery.